KEYTRUDA (pembrolizumab) is a prescription medicine used to treat melanoma, non–small cell lung cancer (NSCLC), head and neck squamous cell cancer (HNSCC), classical Hodgkin lymphoma (cHL)...

KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma, a kind of lung cancer called non–small cell lung cancer (NSCLC), a kind of cancer called head and neck squamous cell cancer (HNSCC), a kind of cancer called classical Hodgkin lymphoma (cHL), a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL), a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL), a kind of bladder and urinary tract cancer called urothelial carcinoma, a kind of cancer that is shown by a laboratory test to be a microsatellite instability-high (MSI‑H) or a mismatch repair deficient (dMMR) solid tumor, a kind of stomach cancer called gastric or gastroesophageal junction (GEJ), a kind of cancer called squamous cell carcinoma of the esophagus, a kind of cancer called cervical cancer, a kind of liver cancer called hepatocellular carcinoma, a kind of skin cancer called Merkel cell carcinoma (MCC), a kind of kidney cancer called renal cell carcinoma (RCC).

KEYTRUDA (pembrolizumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of KEYTRUDA (pembrolizumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.

The order for KEYTRUDA (pembrolizumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Pembrolizumab (formerly lambrolizumab, trade name Keytruda) is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. Other names: MK-3475, lambrolizumab

KEYTRUDA® (pembrolizumab) injection, for intravenous use. Initial U.S. Approval: 2014

Generic Name: pembrolizumab

For injection: 50 mg lyophilized powder in single-dose vial for reconstitution.
Injection: 100 mg/4 mL (25 mg/mL) solution in a single-dose vial

KEYTRUDA Price | Buy Generic Version Of pembrolizumab

with Indian Pharma Network

Indian Pharma Network, Delhi provides access to KEYTRUDA (pembrolizumab) on the Named Patient Import basis in India.

KEYTRUDA (pembrolizumab)

News / Update for KEYTRUDA (pembrolizumab).

For KEYTRUDA (pembrolizumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Learn more I agree European Commission Approves Two New Regimens of Merck’s KEYTRUDA® (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) For More Details

EU approval for Keytruda in head and neck cancer For More Details

Lenvatinib/Pembrolizumab Combo Demonstrates Strong Antitumor Activity in Metastatic RCC For More Details

KEYTRUDA (pembrolizumab) manufacturer and suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand KEYTRUDA (pembrolizumab) on prescription and Import License in Patient's Name only.

For overseas patients, KEYTRUDA (pembrolizumab) can be made available in Send your enquiry to find KEYTRUDA (pembrolizumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Steps to access KEYTRUDA (pembrolizumab) on the Named Patient Import basis.

Step 1.
You send a request for your medicine online:-
Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2.
We verify your prescription and medical details:-
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3.
We source your medicine:-
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4.
We deliver your medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation for Named-Patient import to access KEYTRUDA (pembrolizumab).

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number :07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 6,000 patients.

Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur